Enterische capsules: A Complete Guide to Uses, Advantages and Pharmaceutical Manufacturing

Enteric capsules look like ordinary pills but have special coatings to resist stomach acid and release their contents in the intestine. Enterisch (of gastro-resistant) capsules are specially designed to travel safely through the stomach and dissolve in the small intestine. The term “enteric” comes from the Greek for intestine. In de praktijk, enteric capsules are given a pH-sensitive coating or made of pH-sensitive materials so that they remain intact in the acidic stomach (pH ~1.5–3.5) but rapidly dissolve when they reach the higher pH of the small intestine. In duidelijke bewoordingen, enteric capsules protect the medicine or supplements inside from stomach acid, ensuring the active ingredients are released only once the capsule has passed into the intestines. This simple change in release site can make a big difference in effectiveness and tolerance of many drugs and supplements.

What Are Enteric Capsules and Why Use Them?

Enterisch (zuurbestendig, gastro-resistant) capsules are oral dosage forms designed to resist stomach acid and dissolve in the small intestine. Depending on the product design, the gastro-resistant function may come from the capsulehuls zelf, een enterische coating, of enteric-coated contents such as pellets or granules. This approach is commonly used when an API is sensitive to gastric acid, when release in the stomach is undesirable, or when the formulation is intended to deliver its active ingredient further along the gastrointestinal tract. In de praktijk, they carry drugs through the stomach intact and release them at a higher pH (usually above pH 5.5–6.0). Dit pH-triggered release serves two main purposes:

• Protect Acid-Sensitive Drugs. Veel API's (bijv. certain enzymes, antibiotics like erythromycin, and proton pump inhibitors such as omeprazole) are degraded or inactivated by gastric fluid. An enteric coating shields these APIs until the capsule reaches the duodenum, maximizing absorption and bioavailability.
• Protect the Patient (Gastric Mucosa). Some drugs (notably NSAIDs like aspirin or ibuprofen) irritate or damage the stomach lining. By delaying release until the intestines, enteric capsules mitigate gastric side effects and ulcer risk.
• Target Intestinal Delivery. Enteric capsules are also used to target the lower GI tract (bijv. treating ulcerative colitis or delivering probiotics to the colon). Kortom, the “enteric” approach concentrates drug release where it is most needed or best absorbed.

These benefits explain why formulations range from prescription drugs to supplements and nutraceuticals. Bijvoorbeeld, delivering live probiotics in an enteric capsule ensures the organisms survive stomach acid. Op dezelfde manier, delaying release of painkillers prevents stomach upset. Kortom, enteric capsules enable delayed-release delivery: the capsule passes through the stomach (remaining intact) En opens only when it reaches the higher-pH intestines.

How Enteric Capsules Work (Mechanism of Action)

Although enteric capsules often look just like normal gelatin or veggie capsules, they contain special polymers that hold them together in stomach acid. The secret of enteric capsules is pH. In the stomach’s acidic environment, their special coating or shell stays solid (does not dissolve). Once the capsule moves into the small intestine (typically pH 5.5–7.5), the higher pH triggers the coating to break down. Bijvoorbeeld, a common polymer called HPMCP (hydroxypropyl methylcellulose phthalate) is chosen for enteric capsules because it remains insoluble below about pH 5.5. In de praktijk, a capsule with HPMCP will pass safely through 1–3 hours in the stomach and only start dissolving when it reaches the intestine. This pH-triggered release ensures the capsule’s fill (whether powder, liquid or other forms) is released at the right location.

Regulatory tests confirm this action. By design, an enteric dosage form must niet fall apart or leak its contents in simulated gastric fluid (pH 1.2) for up to 1–2 hours, En moeten fully disintegrate and release its contents in intestinal conditions (pH ~6.8). In eenvoudige bewoordingen, pharmacopeia rules require that no more than 10% of the capsule’s content can be released in stomach-like acid, whereas at least 80% should be released in a higher-pH (intestinal) buffer. This ensures that enteric capsules really do “delay” release until the small intestine.

Materials and Formulation Considerations

Selecting the right materials is crucial for an effective enteric capsule. Key components include the polymeer(S) for the coating (or shell) En hulpstoffen. Common enteric polymers and materials are:

• Methacrylzuurcopolymeren (Eudragit® types). These acrylic or methacrylic polymers can be tailored to dissolve at specific pH thresholds (Bijvoorbeeld, Eudragit L dissolves at pH ~5.5, while Eudragit S requires pH >7). They form the backbone of many pharmaceutical enteric coatings.
• Cellulosederivaten. Voorbeelden zijn onder meer Cellulose Acetate Phthalate (GLB), Hydroxypropylmethylcelluloseftalaat (HPMCP), En HPMCAS (acetate succinate). These materials are traditional enteric polymers that swell and dissolve in intestinal conditions.
• Natural Polymers. In toenemende mate, biologisch afbreekbare materialen leuk vinden schellak, welke (corn protein), natriumalginaat, of chitosan worden gebruikt (often in nutraceutical capsules). These can provide gastric protection with good safety profiles, especially for sensitive products like visolie or probiotics.
• Plasticizers and Excipients. Enteric films usually include plasticizers (Bijv., triethylcitraat, triacetine, PIN 400) to improve flexibility and adhesion. Choice of plasticizer affects film permeability: hydrophilic plasticizers can increase water uptake (risking acid penetration), while hydrophobic ones (like TEC) better preserve acid resistance. Achieving the right balance is a key formulation challenge.

In aanvulling, capsule shell materials themselves may contribute to enteric behavior. Bijvoorbeeld, some products use pre-made acid-resistant capsules to avoid a coating step. Examples include Capsugel’s EnTRinsic® (a cellulose acetate phthalate shell) and CapsCanada’s AR Caps® (a blend of HPMC and hypromellose phthalate). These special shells are designed to remain stable in gastric pH (bijv. AR Caps are stable for 60 min in stomach-like conditions) and then disintegrate at intestinal pH. Using such enteric capsule shells can simplify production (no coating step needed), but requires sourcing the proprietary capsules themselves.

To summarize materials: most enteric capsules use a polymer coating applied post-fill, of een enteric-grade capsule shell; common polymers are methacrylates (Eudragit L/S), CAP/HPMCP, or natural resins. Formulators also adjust plasticizer and solvent systems to ensure a uniform, defect-free film.

Benefits of Using Enteric Capsules

Enteric capsules offer several clear advantages when you need targeted or sensitive delivery:

• Protects Acid-Labile Ingredients: Many ingredients (like enzymes, probiotica, or certain drugs) would be damaged by stomach acid. An enteric capsule shields these sensitive fills on their journey through the stomach. Gelita, a leading gelatin maker, notes that enteric capsules “protect sensitive ingredients on their way through the stomach”, so that the actives reach the intestine intact. Bijvoorbeeld, probiotics or fecal transplant materials for microbiome therapies need this protection to survive until they reach the gut.
• Improved Efficacy and Bioavailability: By releasing the drug in the small intestine, enteric capsules can dramatically improve absorption. Active ingredients can be absorbed where they are meant to, rather than partially lost or degraded in the stomach. This means higher therapeutic effect from the same dose. In eenvoudige bewoordingen, delivering medication precisely to the target site (the intestine) often translates to better performance and more predictable results.
• Reduced Stomach Irritation: Many medications are harsh on the stomach lining (aspirin is a classic example). Enteric capsules keep the drug from contacting the stomach directly, which minimizes GI irritation and nausea. As one review notes, enteric forms avoid the stomach altogether, preventing irritation or unpleasant aftertaste from acids or oils until the capsule reaches the intestine. Kortom, a patient takes the capsule comfortably, and it only “opens” where it’s supposed to.
• Targeted Delivery: Some treatments moeten act in the intestines (like certain colorectal cancer therapies or inflammatory bowel drugs). Enteric capsules are ideal for this. They deliver the contents right to the lower GI tract, ensuring high local concentrations where needed. They also allow time-release effect: door ontwerp, they dissolve more slowly. Bijvoorbeeld, the engineered polymers in an enteric shell typically delay break-down by up to several hours, so the medication release can occur one to two hours after ingestion. This slow, controlled release is useful for formulations with narrow absorption windows.

Algemeen, enteric capsules essentially let you control waar En wanneer your product releases its payload. This is huge for formulations with sensitive enzymes or acid-labile nutrients, for time-release dosing, and for patient comfort. As one capsule expert puts it, the acid-resistant nature of enteric shells “makes them suitable for more specialized drug delivery functions than an ordinary gelatine of plantaardige capsule”.

Acid Resistant Capsules vs. Standard Gelatin & HPMC-capsules

Choosing between Enteric Capsules, standard gelatin capsules, and HPMC capsules is not only a question of shell material. Their behavior in acidic conditions, moisture response, intended release profile, and handling requirements can be quite different. The following comparison gives pharmaceutical manufacturers and production teams a quick overview of the key differences.

Manufacturing Process of Enteric Capsules

The production of enteric capsules follows similar core steps as regular capsules – but with some twists in materials and coating. In a capsule manufacturing facility, the typical stages are:

1. Shell Formation: For hard enteric capsules, roestvrij staal pins or molds are dipped into a viscous solution of the shell material (gelatin or HPMC plus enteric polymers) and then dried. Controlled humidity and temperature ensure the shell cures properly. Softgels are made by depositing two gelatin ribbons (one possibly with polymer added) that are thermally sealed and filled on the fly.
2. Adding Enteric Properties: If using ECDDT, the enteric polymer is already mixed in the shell dough (bijv. HPMC + GLB). If traditional, after shell formation each capsule is coated with an enteric polymer dispersion and dried. Modern approaches like Gelita’s one-step softgel or new hard capsule blends aim to skip that separate coating stage for efficiency.
3. Vulling: Empty shells (now enteric-ready) are sent to a capsule-vulmachine. Capsule fillers position the capsule bottoms, fill them with powder/granules/oil, and then lock on the tops. Semi-automatic or automatic fillers work here. It’s crucial to ensure the process does not compromise the enteric shell. Bijvoorbeeld, excessive moisture or friction could damage an already brittle enteric coating, so some machines feature gentle handling or U-shaped powder guards to prevent spills.
4. Kwaliteitsinspectie: Na het vullen, capsules undergo checks. Dit omvat visuele inspectie (to spot cracks in the shell), weight/dosing accuracy, and crucially, tests for enteric performance. In de praktijk, manufacturers must perform dissolution tests (as described above) to certify each batch’s enteric resistance. Only capsules that meet strict pharmacopeia criteria (no disintegration in acid, complete release in intestinal buffer) are approved for sale.
5. Secundaire verpakking: Eindelijk, filled enteric capsules are typically packaged in bottles of blaarpakketten. A blaarverpakkingsmachine can be used to automate the forming, voeden, afdichting, and cutting of these blister packs, helping manufacturers maintain consistent packaging quality. The handling is similar to other capsules, though some producers note that blister packaging can offer extra protection from moisture (important for cellulose-based shells).

Samengevat, making enteric capsules uses familiar capsule technology but requires extra care in materials and testing. Common steps like pin-dipping or ribbon filling still apply, but with enteric polymers in the mix. Many manufacturers choose advanced capsule manufacturing lines that support multiple capsule materials. As one packaging guide advises, double-check that your equipment can handle “enteric capsules” just as it would gelatin or vegetarian shells. Good equipment design (smooth metal surfaces, appropriate tooling for HPMC, enz.) helps prevent damage to those specialized shells during filling.

Quality Assurance and Testing

Robust QA is essential to ensure enteric function. Key quality metrics include:

• Uniformiteit van de coating: The enteric film must be continuous and consistent. Intra- and inter-batch uniformity checks (bijv. visual inspection or spectroscopic coating thickness measurement) are used to detect any weak spots in the film. A typical target is a specific % gewichtstoename on the core (often around 10±2%), which correlates to the required film thickness.
• Desintegratie testen: Zoals opgemerkt, disintegration is done in two stages. The capsule should show no disintegration (no open gaps) in simulated gastric fluid for the full acid-stage duration. Daarna, it should disintegrate fully in simulated intestinal fluid (typically within 60 notulen). Bijvoorbeeld, one Japanese method confirms an enteric capsule shows no disintegration for 120 min in simulated gastric fluid, then breaks down within 60 min in intestinal fluid.
• Oplossingsprofiel: Disintegration is complemented by quantitative dissolution testing. The protocol typically uses 900 mL of pH ~1.2–1.5 buffer at 37 °C, 100 toerental, for 2h. Drug release must remain low (bijv. <10%) in this acid stage. Then the medium is switched to pH 6.8 buffer, where the drug should release to meet specification (often 80–100% dissolved within a given time). These conditions simulate gastric transit followed by intestinal environment.

Regulatory bodies require that delayed-release forms meet strict dissolution criteria. According to pharmacopeias, acceptance criteria might state, Bijvoorbeeld, “in the acid stage no more than X% release; in the buffer stage at least Y% release within Z minutes.” The specific limits depend on the drug monograph. In de praktijk, manufacturers validate their enteric capsule batches against these pharmacopeial standards using the tests above. Stability testing is also performed to ensure the enteric properties are maintained over shelf life.

Conclusie

Enteric capsules offer a powerful way to improve drug delivery and patient comfort by ensuring medications pass through the stomach without releasing and activate in the small intestine. Enteric capsules enable safer, more effective drug delivery by combining smart formulation and precise manufacturing. Their success depends on stringent coating and testing processes, as well as high-quality encapsulation equipment. Whether you’re producing clinical-trial batches or millions of capsules per year, the right machinery is critical. For any pharmaceutical, nutraceutisch, or supplement company considering enteric formulations, understanding these points is essential for product success.

If you’re an operations or procurement manager looking to produce enteric capsules, JinLu Packing can help you with the right machinery. We offer advanced capsule filling and packaging solutions that are compatible with enteric and other specialty capsules. Our machines are designed for precision, gemak van schoonmaken, and compliance with pharma standards. Ready to optimize your enteric capsule production? Contact JinLu Packing today for a custom solution or quote tailored to your capsule needs.

FAQs About Enteric Capsules

Referenties：
1.The International Pharmacopoeia: Delayed-release capsules (enterische capsules)—— WHO
2.Extended Release Oral Dosage Forms: Ontwikkeling, Evaluation, and Application of In Vitro/In Vivo Correlations —— ONS. Voedsel- en Geneesmiddelenadministratie
3.Commercially Available Enteric Empty Hard Capsules, Production Technology and Application —— Nationale Bibliotheek voor Geneeskunde
4.In Vitro Evaluation of Enteric-Coated HPMC Capsules—Effect of Formulation Factors on Product Performance —— Nationale Bibliotheek voor Geneeskunde
5.Enteric-coated HPMC capsules: Comparison of enteric coatings and investigation of relationship between in-vitro disintegration and dissolution times —— Johannes Gutenberg University Mainz
6.Farmaceutische coating en zijn verschillende benaderingen, een recensie —— Nationale Bibliotheek voor Geneeskunde